Literature DB >> 9350657

Intracellular transport, cell-surface exposure and release of recombinant Tamm-Horsfall glycoprotein.

N Malagolini1, D Cavallone, F Serafini-Cessi.   

Abstract

Human Tamm-Horsfall glycoprotein (T-H), first described as the major urinary glycoprotein, is a glycosylphosphatidyl-inositol (GPI)-anchored membrane protein which mainly resides at the luminal face of cells of the thick ascending limb of Henle's loop (TAL) and early distal convoluted tubules of nephron. Since no human renal cell-line producing T-H is available, T-H cDNA was transfected in HeLa cells and a cell line was selected in which 95% of the cells stably expressed T-H, in order to elucidate the biosynthesis, mechanisms regulating the transport of T-H along the exocytic pathway, exposure at the cell surface and release in soluble form. Treatment of cells with an exogenous reducing agent results in a drastic delay in the conversion from precursor to mature T-H. Since the accumulating T-H-precursor carries glycans not yet processed by Golgi-mannosidases, we propose that the formation of a correct set of intrachain disulphide bonds is required for T-H exit out the endoplasmic reticulum. Even the treatment of cells with an inhibitor of GPI-anchor biosynthesis results in an intracellular accumulation of T-H precursor, loss of T-H localization into Golgi apparatus and reduced surface exposure. These results indicate that the GPI-anchor addition is necessary for T-H delivery to the cell-surface. The release rate of new synthesized T-H shows an initial lag time very likely depending on the time required for T-H surface exposure. A portion of released T-H appears to contain ethanolamine, a component of GPI anchor, indicating that, at least in HeLa cells, a GPI-specific phospholipase contributes to the T-H release. Exposure of cells to monensin and brefeldin A results in a loss of accumulation of T-H in the Golgi perinuclear region and a reduced delivery to the cell surface. Under monensin treatment an intermediate T-H form non-exposed at the cell surface is released in the medium, indicating that a soluble T-H may be produced inside the cell under conditions that alter the Golgi apparatus. If such an event occurs in polarized kidney cells, a T-H release from the basolateral face may be postulated, inasmuch as the GPI-anchor is an apical sorting signal. Since T-H is a powerful autoantigen, the accumulation of soluble T-H in the interstitium of TAL may cause the formation of immunocomplexes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350657     DOI: 10.1038/ki.1997.459

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  20 in total

1.  Activation of the bumetanide-sensitive Na+,K+,2Cl- cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner.

Authors:  Kerim Mutig; Thomas Kahl; Turgay Saritas; Michael Godes; Pontus Persson; James Bates; Hajamohideen Raffi; Luca Rampoldi; Shinichi Uchida; Carsten Hille; Carsten Dosche; Satish Kumar; Maria Castañeda-Bueno; Gerardo Gamba; Sebastian Bachmann
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

2.  Molecular and cellular effects of Tamm-Horsfall protein mutations and their rescue by chemical chaperones.

Authors:  Lijie Ma; Yan Liu; Tarek M El-Achkar; Xue-Ru Wu
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

3.  Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.

Authors:  Anisha Misra; Emile Gleeson; Weiming Wang; Chaobaihui Ye; Paul Zhou; Jason T Kimata
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 4.  Uromodulin: from physiology to rare and complex kidney disorders.

Authors:  Olivier Devuyst; Eric Olinger; Luca Rampoldi
Journal:  Nat Rev Nephrol       Date:  2017-08-07       Impact factor: 28.314

5.  Tamm-Horsfall protein/uromodulin deficiency elicits tubular compensatory responses leading to hypertension and hyperuricemia.

Authors:  Yan Liu; David S Goldfarb; Tarek M El-Achkar; John C Lieske; Xue-Ru Wu
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-10

6.  Tamm-Horsfall glycoprotein interacts with renal outer medullary potassium channel ROMK2 and regulates its function.

Authors:  Aparna Renigunta; Vijay Renigunta; Turgay Saritas; Niels Decher; Kerim Mutig; Siegfried Waldegger
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

7.  Polarized expression of Tamm-Horsfall protein by renal tubular epithelial cells activates human granulocytes.

Authors:  B Kreft; W J Jabs; T Laskay; M Klinger; W Solbach; S Kumar; G van Zandbergen
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

8.  Childhood course of renal insufficiency in a family with a uromodulin gene mutation.

Authors:  Péter Schäffer; Eva Gombos; Krisztina Meichelbeck; András Kiss; P Suzanne Hart; Anthony J Bleyer
Journal:  Pediatr Nephrol       Date:  2010-02-12       Impact factor: 3.714

9.  Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.

Authors:  Sandosh Padmanabhan; Olle Melander; Toby Johnson; Anna Maria Di Blasio; Wai K Lee; Davide Gentilini; Claire E Hastie; Cristina Menni; Maria Cristina Monti; Christian Delles; Stewart Laing; Barbara Corso; Gerjan Navis; Arjan J Kwakernaak; Pim van der Harst; Murielle Bochud; Marc Maillard; Michel Burnier; Thomas Hedner; Sverre Kjeldsen; Björn Wahlstrand; Marketa Sjögren; Cristiano Fava; Martina Montagnana; Elisa Danese; Ole Torffvit; Bo Hedblad; Harold Snieder; John M C Connell; Morris Brown; Nilesh J Samani; Martin Farrall; Giancarlo Cesana; Giuseppe Mancia; Stefano Signorini; Guido Grassi; Susana Eyheramendy; H Erich Wichmann; Maris Laan; David P Strachan; Peter Sever; Denis Colm Shields; Alice Stanton; Peter Vollenweider; Alexander Teumer; Henry Völzke; Rainer Rettig; Christopher Newton-Cheh; Pankaj Arora; Feng Zhang; Nicole Soranzo; Timothy D Spector; Gavin Lucas; Sekar Kathiresan; David S Siscovick; Jian'an Luan; Ruth J F Loos; Nicholas J Wareham; Brenda W Penninx; Ilja M Nolte; Martin McBride; William H Miller; Stuart A Nicklin; Andrew H Baker; Delyth Graham; Robert A McDonald; Jill P Pell; Naveed Sattar; Paul Welsh; Patricia Munroe; Mark J Caulfield; Alberto Zanchetti; Anna F Dominiczak
Journal:  PLoS Genet       Date:  2010-10-28       Impact factor: 5.917

10.  Common genetic variants of the human uromodulin gene regulate transcription and predict plasma uric acid levels.

Authors:  Jia Han; Ying Liu; Fangwen Rao; Caroline M Nievergelt; Daniel T O'Connor; Xingyu Wang; Lisheng Liu; Dingfang Bu; Yu Liang; Fang Wang; Luxia Zhang; Hong Zhang; Yuqing Chen; Haiyan Wang
Journal:  Kidney Int       Date:  2013-01-23       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.